Re-Vana Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Mcclay Research Centre 97 Lisburn Rd, Be...Phone Number
+44 2890975814Website
www.revanatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Re-Vana Therapeutics
Re-Vana Therapeutics is focused on developing sustained release ocular biologics to alleviate the treatment burden of frequent intravitreal injections for patients with sight-threatening diseases. Their innovative technologies include biodegradable, preformed implants like EyeLief and in situ forming implants like OcuLief, designed to deliver a variety of therapeutic modalities. The company aims to improve patient care by providing controlled, sustained release of biologics, peptides, and other molecules over extended periods. Re-Vana collaborates with leading global pharmaceutical companies to advance their preformulation and preclinical studies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Re-Vana Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Re-Vana Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Re-Vana Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Re-Vana Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Re-Vana Therapeutics
Check out if Re-Vana Therapeutics is spiking on competitors!
Check if Re-Vana Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Re-Vana Therapeutics has new funding data
Re-Vana Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Re-Vana Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Re-Vana Therapeutics
Compare insights from companies similar to Re-Vana Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Re-Vana Therapeutics
<$5M
1-10
Private
$15.2M
2016
N/A
Company Profile Activity
Activity Insights
Re-Vana Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Re-Vana Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Re-Vana Therapeutics.
Re-Vana Therapeutics financials insights
Gather financial insights about Re-Vana Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$3.3M
2022
Series A
$11.9M
Re-Vana Therapeutics Tech Stack
A closer look at the technologies used by Re-Vana Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Re-Vana Therapeutics
Sign Up For FreeTo access detailed company insights
Re-Vana Therapeutics is focused on developing sustained release ocular biologics to alleviate the treatment burden of frequent intravitreal injections for patients with sight-threatening diseases. Their innovative technologies include biodegradable, preformed implants like EyeLief and in situ forming implants like OcuLief, designed to deliver a var... Read More
